How Philanthropy is Accelerating Alzheimer’s Breakthroughs with Meg Smith

In this episode of Research Renaissance, host Deborah Westphal is joined by Meg Smith, the Chief Executive Officer of Cure Alzheimer’s Fund. They dive deep into the innovative and high-impact research Cure Alzheimer’s Fund is supporting to prevent, slow, and ultimately cure Alzheimer’s disease. Meg shares her fascinating career journey from law and consulting to leading an organization that is revolutionizing brain disease research.

Together, they discuss:
 ✅ The unique funding model of Cure Alzheimer’s Fund and why it accelerates research breakthroughs
 ✅ The biggest challenges in Alzheimer’s research and how philanthropic funding is filling critical gaps
 ✅ Exciting cutting-edge research on gut microbiome, the immune system, and the role of sleep in brain health
 ✅ The importance of high-risk, high-reward funding in pushing scientific discovery forward
 ✅ How the organization supports researchers and ensures their focus remains in the lab, not on fundraising

Resources & Links:

🔗 Learn more about Cure Alzheimer’s Fund: www.curealz.org
📧 Contact Meg Smith: [e-mail]
🔬 Researchers: Submit inquiries to [e-mail]
🌍 Stay connected with the Karen Toffler Charitable Trust: www.tofflertrust.org

🎧 Listen & Subscribe:
 Subscribe to Research Renaissance for more inspiring conversations on the future of neuroscience and research innovation.

🔔 Don’t forget to rate and review! If you enjoyed this episode, share it with your network and help us spread the word about advancing brain science.

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.